超级碰在线-超级碰碰永久免费视频播放-超级碰碰碰免费视频播放-超级碰碰碰免费视频-亚洲国产99在线精品一区69堂-亚洲高清资源在线观看

上海非利加實(shí)業(yè)有限公司Logo

熱門(mén)詞: 進(jìn)口電動(dòng)溫度調(diào)節(jié)閥結(jié)構(gòu)圖|進(jìn)口電動(dòng)溫度調(diào)節(jié)閥數(shù)據(jù)表進(jìn)口電動(dòng)高溫調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)高溫法蘭調(diào)節(jié)閥進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥

當(dāng)前位置: 首頁(yè) > 所有品牌 > Sunovion
Sunovion
Sunovion Sunovion

美國(guó)Sunovion  

In October 2009, Sepracor Inc., a U.S. pharmaceutical company with a focus in CNS and Respiratory therapies, was acquired by Dainippon Sumitomo Pharma Co., Ltd. (DSP), a top ten, stock exchange-listed pharmaceutical company based in Osaka, Japan.
The move strengthened DSP's North American based drug development pipeline and commercial capabilities. And brought together extensive expertise in two main treatment categories—disorders of the central nervous system (CNS) and respiratory diseases.
In April 2010, DSP's original U.S. subsidiary, Dainippon Sumitomo Pharma America, Inc. (DSPA) was merged into Sepracor. Sunovion is the new company born of this union.

What sets Sunovion apart

Sunovion isn't a household name. But we're confident that it will be. We believe our approach sets us apart. An approach characterized by two things.
First, we look beyond science for science's sake. We look at our patients' needs, and the needs of the healthcare professionals who care for them and find practical ways of developing better treatments.
Second, our focus on our patients' needs has led us to specialize in two distinct and broad-based areas of treatment. These days, more people in the United States from children to seniors are living with respiratory diseases. We are committed to improving their daily lives and helping to minimize the impact of their condition on their everyday activities.
We are equally committed to people suffering from disorders of the central nervous system. People with these conditions need new, advanced therapies to treat them effectively. And we're working to discover, develop and deliver the treatments they need. Sunovion's targeted discovery and development program has already resulted in several treatments such as LUNESTA? (eszopiclone), a medicine that helps people sleep better.
Other development programs under way at Sunovion are focused on treating CNS conditions like anxiety, depression, and epilepsy, and schizophrenia. Latuda? (lurasidone HCl) tablets was approved by the U.S. Food and Drug Administration (FDA) on October 28, 2010 for the treatment of patients with schizophrenia. LATUDA is available by prescription in pharmacies across the United States and Puerto Rico.

關(guān)于我們客戶服務(wù)產(chǎn)品分類法律聲明
主站蜘蛛池模板: 国产边打电话边做对白刺激 | 欧美精品一区二区在线观看 | 一区二区不卡视频 | 久久伊人亚洲 | 久久精品无码一区二区日韩av | a黄毛片 | 欧美在线视频观看 | 亚洲欧美一区二区三区久本道 | 欧美另类亚洲 | 国产一区二区视频在线 | 一区高清 | 日韩精品123 | 免费一看一级毛片人 | 亚洲欧美另类视频 | 成人欧美一区二区三区黑人 | 国产成人精品一区二区三区 | 国产在线精品一区二区三区 | 亚洲精品午夜国产va久久成人 | 免费一看一级毛片全播放 | 国产精品久久国产精麻豆99网站 | 日韩电影免费在线观看网址 | 欧美精品一区二区三区免费观看 | 国产精品久久一区一区 | 国产视频二区 | 91中文| 免费一区 | 国产精品国产三级国产 | 国产色在线 | 精品久久久一二三区 | 91精品观看91久久久久久 | 国外欧美一区另类中文字幕 | 国产第一页视频 | 国产网站在线看 | 国产区精品视频 | 最新国产在线观看 | 日韩欧美一区二区三区四区 | 精品综合一区二区三区 | 国产对白在线播放九色 | 精品国产欧美一区二区三区成人 | 又黄又爽视频在线观看 | 亚洲欧美色视频 |